Editorial Note

Article Outline

• Copyright

As you may know, CRM is now the official journal of the Cardiovascular Revascularization Therapies (CRT) meeting, held this year March 7–9, 2007, in Washington, DC. We are pleased to present a harvest of the best abstracts introduced at this year's meeting, which represent a variety of topics related to interventional cardiology, imaging, vascular biology, cell therapy, and molecular intervention. We look forward to publishing the full manuscripts generated from these abstracts in future issues of CRM.

Our first clinical original article from Barlis et al. aims to determine the outcomes of a strategy of treating patients with unprotected left main who were not ideal candidates for coronary artery bypass grafting with drug-eluting stents. In their submission, de Labriolle et al. aimed to analyze the link between time to treatment and 1-year mortality in patients ≥75 years with ST-elevation myocardial infarction treated with thrombolysis or primary percutaneous coronary intervention.

Deiner et al., in their biology original article, investigated the long-term effects of antiproliferative beta irradiation in a clinically relevant porcine coronary model to address the pathophysiology of late coronary restenosis after antiproliferative vascular interventions. Suzuki et al. evaluated in a porcine renal artery model a novel stent system developed to achieve proper stent positioning and placement with complete ostial coverage.

Wada et al., in the first of four case reports, discovered that stent-in-stent is a useful strategy for stent fracture in central venous obstruction. Next, Zavala-Alarcon et al. aimed to evaluate the results of endovascular treatment of symptomatic vertebro-basilar insufficiency unresponsive to medical therapy.

In our image of the issue, supplied by Roncalli et al., authors present the case of a 47-year-old female with a saccular aneurysm of a branch of the left-circumflex coronary artery associated with multiple fistulae to the right atrium.

In closing, the most controversial study presented at ACC 2007 was the COURAGE trial, and we believe it is time for the medical community to voice their opinions on this matter in a peer-reviewed journal. We invite you to send us comments on the study and its implications on the field of interventional cardiology. We are also pleased to announce that CRM now has an online submission and review Web site, http://ees.elsevier.com/crm. It is our hope that this will simplify the submission process and we encourage all of our readers to continue sending us their interesting work.